Our research Partners are an invaluable part of our team, connecting the xMAP® community with powerful, customizable kits and application and product expertise. On our blog, we’d like to shine the spotlight on our unique Partners and the work they’re doing with xMAP® Technology.
In a recent Nature webinar, Kamala Tyagarajan, PhD, Director of Flow Cytometry Assays and Applications at Luminex, gave a presentation on flow-based multiplex assays for detecting various antibody isotypes to the SARS-CoV-2 virus.
It is an exciting time here at Luminex! The newest member of the xMAP® family, xMAP® INTELLIFLEX, arrived, and our team installed the first system at the Natural and Medical Sciences Institute (NMI) in Reutlingen, Germany. Rob Wilkens, Technical Service Supervisor, and Wilco de Jager, Senior Field Applications Scientist, traveled to NMI to successfully install the system and train the lab users.
The Amnis® CellStream® Flow Cytometer can make a difference in projects where reliably detecting and analyzing EVs is essential. This high-throughput, flow-based system enables accurate analysis of EVs through its high fluorescence sensitivity and the ability to detect particles as small as 50 nm.
The launch of the new xMAP® INTELLIFLEX platform marks a reinvigoration of xMAP® Technology, guided and informed by the voice of our customers. During the development process of the INTELLIFLEX System, we worked with current xMAP users to understand how they use xMAP Technology and what features they’d like to see in the next generation of xMAP Systems.
The INTELLIFLEX System not only has updated optical and fluidics components, but also comes with brand new integrated software, delivering an improved user experience.
Some people have the uncanny ability to solve any problem they are presented with, no matter how big or small. This is particularly true for folks like Maria Escobar, Program Manager in Global Manufacturing and Quality Assurance Operations, who has worked on everything from integration processes and field quality to manufacturing and quality assurance throughout her 14-year career at Luminex.
Throughout the COVID-19 pandemic, we’ve developed tools and assays to support diagnostics, infection control, safety measures, vaccine development, and research. As we continue to manage this evolving public health threat, there is a rising need for insight into the SARS-CoV-2 antibody response and how it changes over time.
One of the hurdles of switching to multiplexing can be knowing what to look for when deciding on which platform best fits your needs. We’ve provided insight on this question and more in our recently published Multiplex Technology Guide, now available for download through our partner, Biocompare.
Extracellular vesicles (EVs) have caught scientists’ attention in recent years. These sub-micron particles are part of a vast cell-to-cell communication network within the body, delivering important biochemical signals from one cell to others.